Cresemba

Cresemba (Isavuconazonium Sulfate) is an antifungal medication used to treat serious fungal infections. It is administered intravenously and is manufactured by Basilea Pharmaceutica Deutschland GmbH.

Cresemba is primarily used for the treatment of invasive aspergillosis and mucormycosis, which are serious fungal infections. It is often prescribed when other treatments are not effective or suitable. The medication works by inhibiting the growth of fungi, helping to manage these infections.

Common effects of Cresemba may include infusion-related reactions such as fever, chills, and headache. Some patients may also experience gastrointestinal issues like nausea or diarrhea. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider.

Cresemba should be used with caution in patients with a history of liver disease or those taking medications that affect liver function. It is important to monitor liver function regularly during treatment. Patients should also be aware of potential drug interactions and inform their healthcare provider of all medications they are taking.

Cresemba may interact with other medications, particularly those metabolized by the liver. This includes drugs like rifampin, phenytoin, and certain antifungal agents. It is also important to avoid grapefruit juice, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medications while taking Cresemba.